Skip to main content
Symbolic photo - Large amounts of data were analyzed for the "Highly Cited Researchers".

Honors & Funding

5 ImmunoSensation Highly Cited Researchers

ImmunoSensation is represented with 5 "Highly Cited Researchers" in Immunology and Cross-Field in this year's international ranking from Clarivate.

According to the creators of the ranking, the individuals on this list of "Highly Cited Researchers" are among the world's most influential one percent of their field.

The benchmark is the frequency with which their scientific publications were cited by other researchers in the past decade (period from 2012t o 2022). The ranking is published annually by the "Web of Science Group" and includes around 7,100 scientists from 67 different countries.

The most cited researchers at ImmunoSensation are:

Thomas Bieber, Cross-Field
Eicke Latz, Immunology
Andreas Schlitzer, Cross-Field
Jonathan L. Schmid-Burgk, Cross-Field
Joachim L. Schultze, Immunology

The University of Bonn is represented with a total of 11 researchers.

Further information: https://recognition.webofscience.com/awards/highly-cited/2023/

Press release University of Bonn: https://www.uni-bonn.de/en/news/213-2023?set_language=en

Related news

Zwei Personen: Links Prof. Pröpstl und rechts Prof. Boztug

Honors & Funding

University of Bonn and University Hospital Bonn strengthen early-career clinical scientists

—The Faculty of Medicine at the University of Bonn and the University Hospital Bonn (UKB) are jointly launching the EKFS doctoral program IMMUNE PILOT, which introduces medical students to clinical-scientific research at an early stage. The structured program is positioned at the interface of immunology, neuroscience, and genetics and is aimed at students with a strong interest in research who aspire to pursue a career as clinician scientists. The program is funded by the Else Kröner-Fresenius Foundation (EKFS).
View entry
PrepAIred

Honors & Funding

Precise active ingredients against pancreatic cancer

—Pancreatic cancer remains one of the deadliest forms of cancer. At the German Cancer Congress 2026, German Cancer Aid is now presenting three large-scale projects that it is funding as part of its “German Alliance for Pancreatic Cancer” funding priority. In the funded project PrepAIred, Bonn researchers , in cooperation with the University of North Carolina (USA), want to use AI-based protein design to specifically combat pancreatic cancer. German Cancer Aid is funding the project with a total of 1.99 million euros over a period of four years.
View entry
Gruppenbild Preistrager Lisec Artz Preisverleihung

Honors & Funding

Niklas Klümper and Varun Venkataramani receive Lisec-Artz Prize

—Dr. Varun Venkataramani of the Faculty of Medicine at Heidelberg University and ImmunoSensation² member Dr. Niklas Klümper of the University Hospital Bonn have been awarded the Lisec Artz Prize for their outstanding cancer research. The University of Bonn Foundation and the University of Bonn Faculty of Medicine presented the awards to the two researchers on Tuesday, November 18, 2025 at the University Hospital Bonn (UKB) as part of the Cluster Science Days event held by the ImmunoSensation² Cluster of Excellence. The prize is worth a total of 15,000 euros.
View entry

Back to the news overview